176 related articles for article (PubMed ID: 27809899)
1. Prenatal sonographic diagnosis of fetal valproate syndrome: a case report.
Kikuchi N; Ohira S; Asaka R; Tanaka K; Takatsu A; Shiozawa T
J Med Case Rep; 2016 Nov; 10(1):312. PubMed ID: 27809899
[TBL] [Abstract][Full Text] [Related]
2. Fetal Valproate Syndrome - Still a Problem Today!
Wiedemann K; Stüber T; Rehn M; Frieauff E
Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
[No Abstract] [Full Text] [Related]
3. A case of fetal valproate syndrome with new features expanding the phenotype.
Seidahmed MZ; Miqdad AM; Al-Dohami HS; Shareefi OM
Saudi Med J; 2009 Feb; 30(2):288-91. PubMed ID: 19198722
[TBL] [Abstract][Full Text] [Related]
4. [Embryofetopathy due to valproate: a pathology only little known. Apropos of 4 cases].
Espinasse M; Manouvrier S; Boute O; Farriaux JP
Arch Pediatr; 1996 Sep; 3(9):896-9. PubMed ID: 8949354
[TBL] [Abstract][Full Text] [Related]
5. Severe fetal valproate syndrome: combination of complex cardiac defect, multicystic dysplastic kidney, and trigonocephaly.
Ozkan H; Cetinkaya M; Köksal N; Yapici S
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):521-4. PubMed ID: 21291342
[TBL] [Abstract][Full Text] [Related]
6. The prescribing of antiepileptic drugs for pregnant Australian women.
Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
[TBL] [Abstract][Full Text] [Related]
7. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
[TBL] [Abstract][Full Text] [Related]
8. Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.
Huang SY; Chueh HY; Shaw SW; Shih JC; Cheng PJ
Am J Obstet Gynecol; 2008 Aug; 199(2):e6-8. PubMed ID: 18486091
[TBL] [Abstract][Full Text] [Related]
9. An anomalous left superior venacava draining into left atrium in association with fetal valproate syndrome.
Sarkar S; Sardar SK; Munian D; Bhattacharya S; Majhi B
Indian J Pediatr; 2013 Jul; 80(7):604-6. PubMed ID: 22678520
[TBL] [Abstract][Full Text] [Related]
10. Fetal Valproate Syndrome.
Mutlu-Albayrak H; Bulut C; Çaksen H
Pediatr Neonatol; 2017 Apr; 58(2):158-164. PubMed ID: 27422007
[TBL] [Abstract][Full Text] [Related]
11. [Embryopathy due to valproic acid with severe malformations in the central nervous system].
Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A
Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769
[TBL] [Abstract][Full Text] [Related]
12. [Metopic craniosynostosis, probable effect of intrauterine exposure to maternal valproate treatment].
Chabrolle JP; Bensouda B; Bruel H; Simon A; Poinsot J; Ickowicz V; Degre S
Arch Pediatr; 2001 Dec; 8(12):1333-6. PubMed ID: 11811028
[TBL] [Abstract][Full Text] [Related]
13. In utero antiepileptic drug exposure: fetal death and malformations.
Meador KJ; Baker GA; Finnell RH; Kalayjian LA; Liporace JD; Loring DW; Mawer G; Pennell PB; Smith JC; Wolff MC;
Neurology; 2006 Aug; 67(3):407-12. PubMed ID: 16894099
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature.
Kozma C
Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853
[TBL] [Abstract][Full Text] [Related]
15. [Prenatal ultrasonographic diagnosis in the epileptic mother on valproic acid. Retrospective study of 161 cases in the central eastern France register of congenital malformations].
Bradaï R; Robert E
J Gynecol Obstet Biol Reprod (Paris); 1998 Jun; 27(4):413-9. PubMed ID: 9690160
[TBL] [Abstract][Full Text] [Related]
16. The teratogenic risk of antiepileptic drug polytherapy.
Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
[TBL] [Abstract][Full Text] [Related]
17. Nuchal edema as the first sign of fetal valproate syndrome.
Witters I; Van Assche F; Fryns JP
Prenat Diagn; 2002 Sep; 22(9):834-5. PubMed ID: 12224082
[No Abstract] [Full Text] [Related]
18. Fetal valproate syndrome: the Irish experience.
Mohd Yunos H; Green A
Ir J Med Sci; 2018 Nov; 187(4):965-968. PubMed ID: 29396778
[TBL] [Abstract][Full Text] [Related]
19. Complex cardiac defect with hypoplastic right ventricle in a fetus with valproate exposure.
ten Berg K; van Oppen AC; Nikkels PG; Gittenberger-de Groot AC; van der Voet GB; Brilstra EH; Lindhout D
Prenat Diagn; 2005 Feb; 25(2):156-8. PubMed ID: 15712340
[TBL] [Abstract][Full Text] [Related]
20. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
